OBJECTIVE.
We In four of these patients, the ct-fetoprotein level fell from more than 200 ng/ml to less than 20 ng/ml during treatment.
In 10 patients with Infiltrating hepatocellular carcinoma, about 70-90% necrosIs was achieved; in six of these patients, the afetoprotein level, which had been more than 200 Ethanol was injected slowly (1 ml in 5-iO sec) and its diffusion was monitored with real-time sonography.
Subjects and Methods

Subjects
As long as the ethanol was seen to disappear rapidly from the needle tip, injection was continued until ethanol pooled in the lesion. were imaged when more precise details were needed. We rated the response to treatment as complete when the CT scans showed no aneas of enhancement within the lesion 1 month after treatment, when this finding was confirmed in the follow-up scans, and when the CT scans and sonograms showed no increase in tumor volume.
We did not use the serologic measurements of tumor marker levels to assess response to treatment because those levels can return to normal when the scans do not show complete response (due to near-total necrosis of the tumor tissue) or decrease even when the scans do show complete response (due to the presence of intrahepatic or extrahepatic lesions that were not detected or were undotectable). We rated the response as partial when the CT scan showed more than 50% necrosis and the tumor marker levels had decreased.
Results
The total volume of alcohol administered per patient ranged from 6 to 165 ml (mean, 57 ml). In all cases, the transaminase level returned to near the level before treatment in 10 days.
Blood alcohol levels immediately after treatment were 10-229 mg/i 00 ml (mean, 82 mg/i 00 ml) and 2 hr later were 3-142 mg/100 ml (mean, 47 mg/mI). In all patients, the values returned to normal within 24 hr. The time required for serum levels of ethanol to return to normal was not appreciably different between patients who were treated with drugs during PEI and those who were not, but the former regained consciousness more easily and quickly. From the day after treatment, imaging examinations showed gas formation within the lesions in about 80% of patients, which was recognizable for 3-1 5 days. Some complications occurred. Three patients with superficially located HCCs, without a cuff of normal hepatic parenchyma between the liven capsule and the lesion, had bleeding into the pentoneum.
In all patients, the decrease in hemoglobin level was minimal (2 g%) and did not require transfusion. Two patients with HCC had necrosis of nonneoplastic tissue adjacent to the tumor with a marked increase in transaminase levels (AST, 1580 and 1341 U/L; ALT, 2263 and 1819 U/L); these patients had pain lasting 2-3 days that required analgeSics (Fig. 2) . In two patients with HCC, sonograms obtained 1 month after ethanol injection showed thrombosis of a segmental portal vein tributary to the tumor; this finding disappeaned spontaneously 3 months after treatment.
Follow-up of Hepatomas
Seven of the 1 0 patients who had an encapsulated lesion had complete response, and three had about 90% necrosis (Figs. 3 and 4) ng/mi to 79, 60, 396, 260, 568 , and 1 500 ng/ml, respectively. During follow-up, new lesions were detected in two patients 6 months after treatment and in one patient 3 months after static lymphadenopathy.
PERCUTANEOUS ETHANOL INJECTION OF LIVER TUMORS
Follow-up of Metastases
The response evaluated by imaging was partial, around 60-80%, in all patients. No complications occurred. Levels of carcinoembryonic antigen, measured 1 month after treatment, decreased in all patients: from 13, 30, 70, 83, 156, 188, 226, and 1396 ng/mI to 9, 18, 8, 27, 42, 108, 35 , and 560 ng/ml, respectively. Dunng follow-up, new hepatic lesions on local recurrences were detected in all patients. One patient died of his underlying disease 9 months after treatment.
Discussion
The rationale for the use of PEI in HCC is based on the fol- 
